Humana's board of directors approved a $3 billion share buyback program, replacing a previous $2.25 billion share repurchase plan.
The buyback program's expiration date is Dec. 31, 2020.
In the third quarter of this year, Humana raised its adjusted earnings per share guidance for 2017 to about $11.60, up from $11.50.